688212 Stock Overview
Shanghai AoHua Photoelectricity Endoscope Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of electronic endoscopic equipment and other consumables in China and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥43.76 |
52 Week High | CN¥66.52 |
52 Week Low | CN¥31.51 |
Beta | -0.70 |
1 Month Change | -15.05% |
3 Month Change | 36.75% |
1 Year Change | -25.96% |
3 Year Change | 20.55% |
5 Year Change | n/a |
Change since IPO | 13.63% |
Recent News & Updates
Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Might Be Having Difficulty Using Its Capital Effectively
Dec 04Earnings Troubles May Signal Larger Issues for Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Shareholders
Nov 01We Think Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Can Stay On Top Of Its Debt
Oct 18Recent updates
Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Might Be Having Difficulty Using Its Capital Effectively
Dec 04Earnings Troubles May Signal Larger Issues for Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Shareholders
Nov 01We Think Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Can Stay On Top Of Its Debt
Oct 18Estimating The Intrinsic Value Of Shanghai Aohua Photoelectricity Endoscope Co., Ltd. (SHSE:688212)
Sep 29Shanghai Aohua Photoelectricity Endoscope Co., Ltd.'s (SHSE:688212) Earnings Haven't Escaped The Attention Of Investors
May 31We Think That There Are Issues Underlying Shanghai Aohua Photoelectricity Endoscope's (SHSE:688212) Earnings
Apr 16Here's Why Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Has Caught The Eye Of Investors
Mar 17Shareholder Returns
688212 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | -4.3% | -2.8% | -1.2% |
1Y | -26.0% | -9.2% | 11.8% |
Return vs Industry: 688212 underperformed the CN Medical Equipment industry which returned -9.2% over the past year.
Return vs Market: 688212 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
688212 volatility | |
---|---|
688212 Average Weekly Movement | 9.2% |
Medical Equipment Industry Average Movement | 8.5% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.8% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688212 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688212's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 1,249 | Xiaozhou Gu | www.aohua.com |
Shanghai AoHua Photoelectricity Endoscope Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of electronic endoscopic equipment and other consumables in China and internationally. It also offers electronic digestive endoscopes, otolaryngoscopes, bronchoscopes, endoscopic diagnostic and treatment consumables, endoscopic accessories, etc. for use in gastroenterology, respiratory, ENT, gynecology, emergency, and other clinical departments. The company was founded in 1994 and is based in Shanghai, China.
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Fundamentals Summary
688212 fundamental statistics | |
---|---|
Market cap | CN¥5.89b |
Earnings (TTM) | CN¥49.97m |
Revenue (TTM) | CN¥750.04m |
117.9x
P/E Ratio7.9x
P/S RatioIs 688212 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688212 income statement (TTM) | |
---|---|
Revenue | CN¥750.04m |
Cost of Revenue | CN¥249.60m |
Gross Profit | CN¥500.44m |
Other Expenses | CN¥450.47m |
Earnings | CN¥49.97m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.37 |
Gross Margin | 66.72% |
Net Profit Margin | 6.66% |
Debt/Equity Ratio | 6.3% |
How did 688212 perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield81%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 00:20 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai Aohua Photoelectricity Endoscope Co., Ltd. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jin Zhang | China International Capital Corporation Limited |
Bo Yu | China International Capital Corporation Limited |
Zhu Chen | Citic Securities Co., Ltd. |